SlideShare a Scribd company logo
RECENT DEVELOPMENTS IN THE
TREATMENTS OF
ATHEROSCLEROSIS.
1
WHAT IS ATHEROSCLEROSIS?
 Atherosclerosis (or arteriosclerotic vascular
disease) is a condition where the arteries
become narrowed and hardened due to an
excessive build up of plaque around the artery
wall.The disease disrupts the flow of blood
around the body, posing serious
cardiovascular complications.
2
WHY SHOULD WE KNOW ABOUT
ATHEROSCLEROSIS?
 Statins are highly effective in lowering low-
density lipoprotein (LDL) cholesterol levels,
and therefore represent the first-line
treatment for prevention of cardiovascular
disease. Despite this, a substantial proportion
(>50%) of high-risk patients do not meet
guideline targets for LDL cholesterol
reduction.This clearly indicates an unmet
need for additional treatment to improve LDL
goal achievement.
3
 Although atherosclerosis usually manifests in
later life, its early phases are present in
teenagers and young adults.
 The clinical manifestations of atherosclerosis,
such as CVD, are common in Western and
urban populations, and are an important and
common cause of death and disease.
 Statins produce significant toxicity at high
doses in a variety of animal species.
4
 Effects can be prevented by administering
mevalonate, the product of the reaction
catalysed by HMG-CoA reductase.This indicates
that these toxic effects are mostly, if not entirely,
attributable to extreme inhibition of the enzyme
at high doses.
 The risk of myopathy with statins is increased by
concomitant administration of certain other
drugs, particularly gemfibrozil and to a lesser
extent, possibly some other fibrates, and niacin.
5
6
TREATMENT:
 1)HDL usage : Boosting HDL cholesterol’s
role as an ally against heart disease. However,
the failure and increased mortality rates of
one HDL-raising trial drug, torcetrapib, in
2006 highlights the challenges of discovering
the right therapy.
7
 It has raised concerns that maybe it’s not
raising the right kinds of HDL. All forms of
LDL are bad, HDL is a much more
complicated story.HDL is called the “good
cholesterol,” but in truth, HDL particles vary
in size and composition, and we don’t know if
all forms of HDL are good.
8
9
 2)Anti inflammatories: Inflammation plays a key
role in plaque formation and subsequent plaque
rupture, which can lead to a heart attack. Statins
along with lowering LDL cholesterol have anti
inflammatory effect which help in preventing the
atheromatous plaque rupture.
 But, we have to develop entirely new types of
drugs that specifically prevent or reduce
inflammation in artery walls, by attacking root
causes.
Immunotherapeutic
approaches:
1) Lipid BasedVaccines: This approach involves
the inhibition of atherosclerotic lesion
formation, associated with increased CETP
antibodies, decreased CETP activity, and
modified lipoprotein profiles.
10
 2)VaccinationStrategies Based on Epitopes of
Oxidized LDL: The different epitopes of oxidized LDL
(oxLDL) induce atherogenic immune responses.This is an
effective tool for modulation of the immune response to
oxLDL.Also, a number of studies have shown that
immunization against oxLDL reduces atherosclerosis.
11
 Immunization with a peptide of apoB-100 (p210)
fused to the B subunit of cholera toxin (CTB), which
binds to a ganglioside on mucosal epithelia for 12
weeks, caused a 35% reduction in aortic lesion size in
atherosclerosis-prone apoE-deficiency.
 3) Heat Shock Proteins:Autoimmunity to heat shock
proteins (HSPs) is one element in atherosclerosis-
induced immune responses. Repeated mucosal
administration of Mycobacterium HSP60/65, both
orally and nasally, inhibited atherosclerotic lesion
formation in LDL-receptor-deficient mice.
12
CONCLUSION:-
 In order to reduce further myocardial deaths
we have to find safer and effective
treatments methods against atherosclerosis
and thereby reducing mortality and
morbidity.
 Right drug for the given condition.
 Atherosclerosis can be prevented by lifestyle
changes and by eating healthy food.
13
14

More Related Content

What's hot

Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Ayman Mohammed
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis pathophysiology
Atherosclerosis pathophysiology Atherosclerosis pathophysiology
Atherosclerosis pathophysiology
Vara Lakshmi
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Rithik Katariya
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Biochemistry Mcu
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
JYOTI PACHISIA
 
Atherosclerosis and it’s complications
Atherosclerosis and it’s complicationsAtherosclerosis and it’s complications
Atherosclerosis and it’s complications
PiyushaZore1
 
Artherosclerosis
ArtherosclerosisArtherosclerosis
Artherosclerosis
Dr. Bijay kumar Sah
 
Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)
HilBar2014
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
suraj wanjari
 
atherosclerosis
atherosclerosisatherosclerosis
atherosclerosis
Diksha Singh
 
Atherosclerosis by neha
Atherosclerosis by nehaAtherosclerosis by neha
Atherosclerosis by neha
Neha Vishwakarma
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Maariah Qibtiah
 
PAD- Atherosclerosis
PAD- Atherosclerosis PAD- Atherosclerosis
PAD- Atherosclerosis
Layla Aziz
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Mahendar S
 
Arteriosclerosis 6
Arteriosclerosis 6Arteriosclerosis 6
Arteriosclerosis 6
Forensic Pathology
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Mohammed Musa
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Norazila Zulkarnain
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Namrata Chhabra
 

What's hot (19)

Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis pathophysiology
Atherosclerosis pathophysiology Atherosclerosis pathophysiology
Atherosclerosis pathophysiology
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis and it’s complications
Atherosclerosis and it’s complicationsAtherosclerosis and it’s complications
Atherosclerosis and it’s complications
 
Artherosclerosis
ArtherosclerosisArtherosclerosis
Artherosclerosis
 
Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
atherosclerosis
atherosclerosisatherosclerosis
atherosclerosis
 
Atherosclerosis by neha
Atherosclerosis by nehaAtherosclerosis by neha
Atherosclerosis by neha
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
PAD- Atherosclerosis
PAD- Atherosclerosis PAD- Atherosclerosis
PAD- Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Arteriosclerosis 6
Arteriosclerosis 6Arteriosclerosis 6
Arteriosclerosis 6
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 

Similar to Recent developments in the treatment of atherosclerosis

Atherosclerosis
Atherosclerosis Atherosclerosis
Atherosclerosis
DR RML DELHI
 
IHD ema_2020.pdf
IHD ema_2020.pdfIHD ema_2020.pdf
IHD ema_2020.pdf
Imtiyaz60
 
Pathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptxPathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptx
nikita01kharal
 
blood lipids.docx
blood lipids.docxblood lipids.docx
blood lipids.docx
gigi867701
 
Lect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and AtherosclerosisLect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and Atherosclerosis
Imhotep Virtual Medical School
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
A-aziz Sultan
 
Cholesterol
CholesterolCholesterol
Cholesterol
Doyee5
 
17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx
anjukowsika
 
atherosclerosis.pptx
atherosclerosis.pptxatherosclerosis.pptx
atherosclerosis.pptx
ajaybhat49
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
utsav parmar
 
Cad
CadCad
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
Ancestral Health Society
 
ARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptxARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptx
SAMOEINESH
 
New microsoft word document (2)
New microsoft word document (2)New microsoft word document (2)
New microsoft word document (2)
ayooy1992
 
Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
Areej Abu Hanieh
 
Atherosclerosis ppt
Atherosclerosis pptAtherosclerosis ppt
Atherosclerosis ppt
Dr Shumayla Aslam-Faiz
 
Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6
lunacovas
 
lipid-lowering drugs
lipid-lowering drugslipid-lowering drugs
lipid-lowering drugs
Elham Khaled
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
A Al Sumon
 
The role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic diseaseThe role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic disease
Yumna Ali
 

Similar to Recent developments in the treatment of atherosclerosis (20)

Atherosclerosis
Atherosclerosis Atherosclerosis
Atherosclerosis
 
IHD ema_2020.pdf
IHD ema_2020.pdfIHD ema_2020.pdf
IHD ema_2020.pdf
 
Pathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptxPathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptx
 
blood lipids.docx
blood lipids.docxblood lipids.docx
blood lipids.docx
 
Lect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and AtherosclerosisLect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and Atherosclerosis
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Cholesterol
CholesterolCholesterol
Cholesterol
 
17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx
 
atherosclerosis.pptx
atherosclerosis.pptxatherosclerosis.pptx
atherosclerosis.pptx
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Cad
CadCad
Cad
 
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
 
ARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptxARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptx
 
New microsoft word document (2)
New microsoft word document (2)New microsoft word document (2)
New microsoft word document (2)
 
Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
 
Atherosclerosis ppt
Atherosclerosis pptAtherosclerosis ppt
Atherosclerosis ppt
 
Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6
 
lipid-lowering drugs
lipid-lowering drugslipid-lowering drugs
lipid-lowering drugs
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
The role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic diseaseThe role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic disease
 

Recently uploaded

RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Celine George
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
adhitya5119
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 

Recently uploaded (20)

RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 

Recent developments in the treatment of atherosclerosis

  • 1. RECENT DEVELOPMENTS IN THE TREATMENTS OF ATHEROSCLEROSIS. 1
  • 2. WHAT IS ATHEROSCLEROSIS?  Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall.The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. 2
  • 3. WHY SHOULD WE KNOW ABOUT ATHEROSCLEROSIS?  Statins are highly effective in lowering low- density lipoprotein (LDL) cholesterol levels, and therefore represent the first-line treatment for prevention of cardiovascular disease. Despite this, a substantial proportion (>50%) of high-risk patients do not meet guideline targets for LDL cholesterol reduction.This clearly indicates an unmet need for additional treatment to improve LDL goal achievement. 3
  • 4.  Although atherosclerosis usually manifests in later life, its early phases are present in teenagers and young adults.  The clinical manifestations of atherosclerosis, such as CVD, are common in Western and urban populations, and are an important and common cause of death and disease.  Statins produce significant toxicity at high doses in a variety of animal species. 4
  • 5.  Effects can be prevented by administering mevalonate, the product of the reaction catalysed by HMG-CoA reductase.This indicates that these toxic effects are mostly, if not entirely, attributable to extreme inhibition of the enzyme at high doses.  The risk of myopathy with statins is increased by concomitant administration of certain other drugs, particularly gemfibrozil and to a lesser extent, possibly some other fibrates, and niacin. 5
  • 6. 6
  • 7. TREATMENT:  1)HDL usage : Boosting HDL cholesterol’s role as an ally against heart disease. However, the failure and increased mortality rates of one HDL-raising trial drug, torcetrapib, in 2006 highlights the challenges of discovering the right therapy. 7
  • 8.  It has raised concerns that maybe it’s not raising the right kinds of HDL. All forms of LDL are bad, HDL is a much more complicated story.HDL is called the “good cholesterol,” but in truth, HDL particles vary in size and composition, and we don’t know if all forms of HDL are good. 8
  • 9. 9  2)Anti inflammatories: Inflammation plays a key role in plaque formation and subsequent plaque rupture, which can lead to a heart attack. Statins along with lowering LDL cholesterol have anti inflammatory effect which help in preventing the atheromatous plaque rupture.  But, we have to develop entirely new types of drugs that specifically prevent or reduce inflammation in artery walls, by attacking root causes.
  • 10. Immunotherapeutic approaches: 1) Lipid BasedVaccines: This approach involves the inhibition of atherosclerotic lesion formation, associated with increased CETP antibodies, decreased CETP activity, and modified lipoprotein profiles. 10
  • 11.  2)VaccinationStrategies Based on Epitopes of Oxidized LDL: The different epitopes of oxidized LDL (oxLDL) induce atherogenic immune responses.This is an effective tool for modulation of the immune response to oxLDL.Also, a number of studies have shown that immunization against oxLDL reduces atherosclerosis. 11
  • 12.  Immunization with a peptide of apoB-100 (p210) fused to the B subunit of cholera toxin (CTB), which binds to a ganglioside on mucosal epithelia for 12 weeks, caused a 35% reduction in aortic lesion size in atherosclerosis-prone apoE-deficiency.  3) Heat Shock Proteins:Autoimmunity to heat shock proteins (HSPs) is one element in atherosclerosis- induced immune responses. Repeated mucosal administration of Mycobacterium HSP60/65, both orally and nasally, inhibited atherosclerotic lesion formation in LDL-receptor-deficient mice. 12
  • 13. CONCLUSION:-  In order to reduce further myocardial deaths we have to find safer and effective treatments methods against atherosclerosis and thereby reducing mortality and morbidity.  Right drug for the given condition.  Atherosclerosis can be prevented by lifestyle changes and by eating healthy food. 13
  • 14. 14

Editor's Notes

  1. mm